Given the emerging strong crosstalk between the (intracellular) complement system and the NLRP3 inflammasome (162), we would argue that this may be a functional relationship that should be further explored with regard to its role in MS pathology. The gene discussed is NLRP3; the disease is myeloid sarcoma.